首页> 外国专利> PHARMACEUTICAL COMPOSITION INDUCING GLUTATHIONE BIOSYNTHESIS, GLUTATHIONE TRANSFERASE ACTIVITY AND SHOWING ANTITOXIC, RADIOPROTECTIVE AND ANTIHYPOXIC ACTION AND METHODS OF TREATMENT, PROPHYLAXIS AND PROTECTION USING THEREOF

PHARMACEUTICAL COMPOSITION INDUCING GLUTATHIONE BIOSYNTHESIS, GLUTATHIONE TRANSFERASE ACTIVITY AND SHOWING ANTITOXIC, RADIOPROTECTIVE AND ANTIHYPOXIC ACTION AND METHODS OF TREATMENT, PROPHYLAXIS AND PROTECTION USING THEREOF

机译:诱导谷胱甘肽生物合成,谷胱甘肽转移酶活性和抗氧化,放射防护和抗氧作用的药物成分及其治疗,预防和预防方法

摘要

FIELD: medicine, biochemistry. SUBSTANCE: pharmaceutical composition has pharmaceutically acceptable carrier and an active component - effective amount of a mixture of L-glutamic acid, glycine and sulfur-containing amino acid taken from the group including cysteine, cystine and methionine at mass ratio of components = 1:1:1. Pharmaceutical composition can be prepared in the form of powder, tablet or solution. It has each of the indicated components at amount 0.1-0.2 g per a single dose. Pharmaceutically acceptable carrier consists of water or methylcellulose. Composition is used for prophylaxis and treatment of chronic alcoholism, intoxication with aromatic hydrocarbons and for resistance increase to hypoxia and protection from radiation damage by sublingual administration at effective dose. EFFECT: enhanced effectiveness of composition. 8 cl, 1 dwg , 11 tbl
机译:领域:医学,生物化学。物质:药物组合物具有药学上可接受的载体和活性成分-有效成分的L-谷氨酸,甘氨酸和含硫氨基酸的混合物,以组分的质量比= 1:1选自半胱氨酸,胱氨酸和蛋氨酸:1。药物组合物可以粉末,片剂或溶液的形式制备。每种指示成分的含量为每单剂0.1-0.2 g。药学上可接受的载体由水或甲基纤维素组成。该组合物用于预防和治疗慢性酒精中毒,芳香烃中毒以及通过以有效剂量舌下给药来增强对低氧的抵抗力并防止辐射损伤。效果:增强了合成效果。 8厘升,1载重吨,11桶

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号